article thumbnail

Improving physiological relevance in neurological disease drug development

Drug Discovery World

The interview highlights their need to develop assays that are amenable to long term use to support their clients with drug development, and how bit.bio’s deterministically programmed ioMicroglia have helped them develop assays with increased physiological relevance and consistency, towards this goal.

article thumbnail

Case Study: Consistent assays for neurological disease drug development

Drug Discovery World

A new Case Study is now available to download for free entitled ‘ Improving physiological relevance in neurological disease drug development. Download ‘ Improving physiological relevance in neurological disease drug development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Key drug development trends and predictions for 2024

Drug Discovery World

Dr Julie Warner is Vice President of Regulatory Affairs at drug development consultancy, Boyds. In this article, she provides her expert insights into the key trends and developments expected to shape the global drug development industry this year.

article thumbnail

First spaceflight mission for drug development lab

Drug Discovery World

On the inaugural PIL-BOX-01 mission, Eli Lilly is partnering with Redwire to conduct three experiments focused on developing advanced treatments for diabetes, cardiovascular disease, and pain. The post First spaceflight mission for drug development lab appeared first on Drug Discovery World (DDW).

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management.

article thumbnail

Latest Guide: Streamline your drug development pathway

Drug Discovery World

In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Organisations (CROs) poses potential hurdles – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimisation and clinical trials.

article thumbnail

Drug development practices to improve public health policy 

Drug Discovery World

For statisticians working in drug development, such ambiguity is an anathema. 11 These standards are required by the FDA and the global nature of drug development means that they have now become the de facto standard. . Importance of protocols for simulation studies in clinical drug development.